FILE PHOTO: A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange in New York, U.S., July 29, 2019. REUTERS/Brendan McDermid
Pfizer shares jumped 10.16%, although they were off earlier highs, after the company said the vaccine was more than 90% effective in a large-scale clinical trial for which it will now seek a U.S. emergency use authorization. U.S.-listed shares of BioNTech were up 9.89%.
Oh shit, is the orange gonna take credit for this.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: